Abbott trial on preterm infant formula linked to NEC disease kicks off this week
Fast CompanySimilac baby formula maker Abbott is expected to face a trial on Monday over claims that its formula for preterm infants used in neonatal intensive care units causes a potentially deadly bowel disease, the second trial out of hundreds of similar lawsu…